Myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays.
<h4>Background</h4>Myasthenia gravis is a disorder of neuromuscular transmission associated with autoantibodies against the nicotinic acetylcholine receptor. We have previously developed a customized protein macroarray comprising 1827 potential human autoantigens, which permitted to disc...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2013
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/be1c3cca77104d01b8019b63aadc4bfd |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:be1c3cca77104d01b8019b63aadc4bfd |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:be1c3cca77104d01b8019b63aadc4bfd2021-11-18T07:55:01ZMyasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays.1932-620310.1371/journal.pone.0058095https://doaj.org/article/be1c3cca77104d01b8019b63aadc4bfd2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23483977/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Myasthenia gravis is a disorder of neuromuscular transmission associated with autoantibodies against the nicotinic acetylcholine receptor. We have previously developed a customized protein macroarray comprising 1827 potential human autoantigens, which permitted to discriminate sera of patients with different cancers from sera of healthy controls, but has not yet been evaluated in antibody-mediated autoimmune diseases.<h4>Objective</h4>To determine whether autoantibody signatures obtained by protein macroarray separate sera of patients with myasthenia gravis from healthy controls.<h4>Methods</h4>Sera of patients with acetylcholine receptor antibody-positive myasthenia gravis (n = 25) and healthy controls (n = 32) were analyzed by protein macroarrays comprising 1827 peptide clones.<h4>Results</h4>Autoantibody signatures did not separate patients with myasthenia gravis from controls with sufficient sensitivity, specificity, and accuracy. Intensity values of one antigen (poly A binding protein cytoplasmic 1, p = 0.0045) were higher in patients with myasthenia gravis, but the relevance of this and two further antigens, 40S ribosomal protein S13 (20.8% vs. 0%, p = 0.011) and proteasome subunit alpha type 1 (25% vs. 3.1%, p = 0.035), which were detected more frequently by myasthenia gravis than by control sera, currently remains uncertain.<h4>Conclusion</h4>Seroreactivity profiles of patients with myasthenia gravis detected by a customized protein macroarray did not allow discrimination from healthy controls, compatible with the notion that the autoantibody response in myasthenia gravis is highly focussed against the acetylcholine receptor.Anne BeckerNicole LudwigAndreas KellerBjörn TackenbergChristian EienbrökerWolfgang H OertelKlaus FassbenderEckart MeeseKlemens RuprechtPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 3, p e58095 (2013) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Anne Becker Nicole Ludwig Andreas Keller Björn Tackenberg Christian Eienbröker Wolfgang H Oertel Klaus Fassbender Eckart Meese Klemens Ruprecht Myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays. |
| description |
<h4>Background</h4>Myasthenia gravis is a disorder of neuromuscular transmission associated with autoantibodies against the nicotinic acetylcholine receptor. We have previously developed a customized protein macroarray comprising 1827 potential human autoantigens, which permitted to discriminate sera of patients with different cancers from sera of healthy controls, but has not yet been evaluated in antibody-mediated autoimmune diseases.<h4>Objective</h4>To determine whether autoantibody signatures obtained by protein macroarray separate sera of patients with myasthenia gravis from healthy controls.<h4>Methods</h4>Sera of patients with acetylcholine receptor antibody-positive myasthenia gravis (n = 25) and healthy controls (n = 32) were analyzed by protein macroarrays comprising 1827 peptide clones.<h4>Results</h4>Autoantibody signatures did not separate patients with myasthenia gravis from controls with sufficient sensitivity, specificity, and accuracy. Intensity values of one antigen (poly A binding protein cytoplasmic 1, p = 0.0045) were higher in patients with myasthenia gravis, but the relevance of this and two further antigens, 40S ribosomal protein S13 (20.8% vs. 0%, p = 0.011) and proteasome subunit alpha type 1 (25% vs. 3.1%, p = 0.035), which were detected more frequently by myasthenia gravis than by control sera, currently remains uncertain.<h4>Conclusion</h4>Seroreactivity profiles of patients with myasthenia gravis detected by a customized protein macroarray did not allow discrimination from healthy controls, compatible with the notion that the autoantibody response in myasthenia gravis is highly focussed against the acetylcholine receptor. |
| format |
article |
| author |
Anne Becker Nicole Ludwig Andreas Keller Björn Tackenberg Christian Eienbröker Wolfgang H Oertel Klaus Fassbender Eckart Meese Klemens Ruprecht |
| author_facet |
Anne Becker Nicole Ludwig Andreas Keller Björn Tackenberg Christian Eienbröker Wolfgang H Oertel Klaus Fassbender Eckart Meese Klemens Ruprecht |
| author_sort |
Anne Becker |
| title |
Myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays. |
| title_short |
Myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays. |
| title_full |
Myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays. |
| title_fullStr |
Myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays. |
| title_full_unstemmed |
Myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays. |
| title_sort |
myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2013 |
| url |
https://doaj.org/article/be1c3cca77104d01b8019b63aadc4bfd |
| work_keys_str_mv |
AT annebecker myastheniagravisanalysisofserumautoantibodyreactivitiesto1827potentialhumanautoantigensbyproteinmacroarrays AT nicoleludwig myastheniagravisanalysisofserumautoantibodyreactivitiesto1827potentialhumanautoantigensbyproteinmacroarrays AT andreaskeller myastheniagravisanalysisofserumautoantibodyreactivitiesto1827potentialhumanautoantigensbyproteinmacroarrays AT bjorntackenberg myastheniagravisanalysisofserumautoantibodyreactivitiesto1827potentialhumanautoantigensbyproteinmacroarrays AT christianeienbroker myastheniagravisanalysisofserumautoantibodyreactivitiesto1827potentialhumanautoantigensbyproteinmacroarrays AT wolfganghoertel myastheniagravisanalysisofserumautoantibodyreactivitiesto1827potentialhumanautoantigensbyproteinmacroarrays AT klausfassbender myastheniagravisanalysisofserumautoantibodyreactivitiesto1827potentialhumanautoantigensbyproteinmacroarrays AT eckartmeese myastheniagravisanalysisofserumautoantibodyreactivitiesto1827potentialhumanautoantigensbyproteinmacroarrays AT klemensruprecht myastheniagravisanalysisofserumautoantibodyreactivitiesto1827potentialhumanautoantigensbyproteinmacroarrays |
| _version_ |
1718422754335653888 |